Structural and photocatalytic properties of Ni-TiO2 photocatalysts prepared by mechanochemical synthesis assisted with calcination

In the study the mechanochemical synthesis in the planetary ball mill was used to prepare photocatalytic materials obtained on the basis of TiO2 and nickel(II) acetylacetonate as a Ni2+ source. Three materials with different contents of Ni2+: 5, 10 and 20% wt. were prepared. The obtained materials were calcinated at 800°C for 1 h. Their physicochemical properties were investigated using the N2 adsorption/desorption, FT-IR/PAS, XRD, UV-Vis/DRS and SEM methods. Additionally, thermal stability of the obtained materials was examined (TGA/DTG/DTA). Photocatalytic activity of the samples was tested in relation to the aqueous solution of Safranin T (initial concentration C0 = 1×10-5 mol L-1) at the visible light (Vis). The results indicate that the mechanochemical synthesis is an effective and simple method for preparing materials with photocatalytic properties. All obtained materials were characterized by greater photocatalytic activity compared to the initial TiO2

Characterization of Multimodal Silicas Using TG/DTG/DTA, Q-TG, and DSC Methods

The formation of hierarchical, multimodal porosity materials with controlled shape and size of pores is the essential challenge in materials science. Properties of silica materials depend largely on different features: crystal structure, dispersity, surface composition, and porosity as well as the method of preparation and possible modification. In this paper, multimodal silicas obtained using different additives are presented. A-50 and A-380 aerosils and wide-porous SiO2 milled at 300 rpm were used as the additives in the sol stage at 20 °C, the sol–gel stage followed by hydrothermal modification (HTT) at 200 °C, or in the mechanochemical treatment (MChT) process. The characterizations were made by application of N2 adsorption/desorption, SEM imaging, quasi-isothermal thermogravimetry (Q-TG), dynamic thermogravimetry/derivative thermogravimetry/differential thermal analysis (TG/DTG/DTA), and cryoporometry differential scanning calorimetry (DSC) methods. Results showed that such a one-step preparation method is convenient and makes it possible to obtain multimodal silicas of differentiated porous structures and surface chemistry

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation or atrial flutter

AIMS: The aim of the study was to evaluate the prevalence of left atrial thrombus (LAT) on transoesophageal echocardiography (TOE) in patients with atrial fibrillation or atrial flutter (AF/AFl) with reference to the presence of heart failure (HF) and its subtypes. METHODS AND RESULTS: The research is a sub-study of the multicentre, prospective, observational Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry, which comprised 3109 consecutive patients with AF/AFl undergoing TOE prior to direct current cardioversion or catheter ablation. TOE parameters, including presence of LAT, were compared between patients with and without HF and across different subtypes of HF, including HF with preserved (HFpEF), mid-range (HFmrEF), and reduced ejection fraction (HFrEF). HF was diagnosed in 1336 patients (43%). HF patients had higher prevalence of LAT than non-HF patients (12.8% vs. 4.4%; P < 0.001). LAT presence increased with more advanced type of systolic dysfunction (HFpEF vs. HFmrEF vs. HFrEF: 7.4% vs. 10.5% vs. 20.3%; P < 0.001). Univariate analysis revealed that HFrEF (odds ratio [OR] 4.13; 95% confidence interval [95% CI]: 3.13-5.46), but not HFmrEF or HFpEF, was associated with the presence of LAT. Multivariable logistic regression indicated that lower left ventricular ejection fraction (OR per 1%: 0.94; 95% CI 0.93-0.95) was an independent predictor of LAT formation. Receiver operator characteristic analysis showed LVEF ≤48% adequately predicted increased risk of LAT presence (area under the curve [AUC] 0.74; P < 0.0001). CONCLUSION: The diagnosis of HFrEF, but neither HFmrEF nor HFpEF, confers a considerable risk of LAT presence despite widespread utilization of adequate anticoagulation

Echocardiographic predictors of thrombus in left atrial appendage-The role of novel transthoracic parameters

INTRODUCTION: The left atrium appendage thrombus (LAAT) formation is a complex process. A CHA2DS2-VASc scale is an established tool for determining the thromboembolic risk and initiation of anticoagulation treatment in patients with atrial fibrillation or flutter (AF/AFL). We aimed to identify whether any transthoracic echocardiography (TTE) parameters could have an additional impact on LAAT detection. METHODS: That is a sub-study of multicenter, prospective, observational study LATTEE (NCT03591627), which enrolled 3,109 consecutive patients with AF/AFL referred for transesophageal echocardiography (TEE) before cardioversion or ablation. RESULTS: LAAT was diagnosed in 8.0% of patients. The univariate logistic regression analysis [based on pre-specified in the receiver operating characteristic (ROC) analysis cut-off values with AUC ≥ 0.7] identified left ventricular ejection fraction (LVEF) ≤ 48% and novel TTE parameters i.e., the ratios of LVEF and left atrial diameter (LAD) ≤ 1.1 (AUC 0.75; OR 5.64; 95% CI 4.03-7.9; p < 0.001), LVEF to left atrial area (LAA) ≤ 1.7 (AUC 0.75; OR 5.64; 95% CI 4.02-7.9; p < 0.001), and LVEF to indexed left atrial volume (LAVI) ≤ 1.1 (AUC 0.75, OR 6.77; 95% CI 4.25-10.8; p < 0.001) as significant predictors of LAAT. In a multivariate logistic regression analysis, LVEF/LAVI and LVEF/LAA maintained statistical significance. Calculating the accuracy of the abovementioned ratios according to the CHA2DS2-VASc scale values revealed their highest predictive power for LAAT in a setting with low thromboembolic risk. CONCLUSION: Novel TTE indices could help identify patients with increased probability of the LAAT, with particular applicability for patients at low thromboembolic risk

Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry

BACKGROUND: Atrial fibrillation (AF) and flutter (AFl) increase the risk of thromboembolism. The aim of the study was to assess the prevalence of left atrial thrombus (LAT) in AF/AFl in relation to oral anticoagulation (OAC). METHODS: LATTEE (NCT03591627) was a multicenter, prospective, observational study enrolling consecutive patients with AF/AFl referred for transesophageal echocardiography before cardioversion or ablation. RESULTS: Of 3109 patients enrolled, 88% were on chronic, 1.5% on transient OAC and 10% without OAC. Of patients on chronic OAC, 39% received rivaroxaban, 30% dabigatran, 14% apixaban and 18% vitamin K antagonists (VKA). Patients on apixaban were oldest, had the worst renal function and were highest in both bleeding and thromboembolic risk, and more often received reduced doses. Prevalence of LAT was 8.0% (7.3% on chronic OAC vs. 15% without OAC; p &lt; 0.01). In patients on VKA, prevalence of LAT was doubled compared to patients on non-VKA-OACs (NOACs) (13% vs. 6.0%; p &lt; 0.01), even after propensity score weighting (13% vs. 7.5%; p &lt; 0.01). Prevalence of LAT in patients on apixaban was higher (9.8%) than in those on rivaroxaban (5.7%) and dabigatran (4.7%; p &lt; 0.01 for both comparisons), however, not after propensity score weighting. CONCLUSIONS: The prevalence of LAT in AF is non-negligible even on chronic OAC. The risk of LAT seems higher on VKA compared to NOAC, and similar between different NOACs